🇺🇸 FDA
Patent

US 7521175

Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

granted A61PA61P35/00

Quick answer

US patent 7521175 (Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571) held by The Regents of the University of California expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P35/00